CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content

Tenofovir disoproxil fumarate

Last Updated: October 2, 2008
Result type: Reports
Project Number: SR0148-000
Product Line: Reimbursement Review

Generic Name: Tenofovir disoproxil fumarate

Brand Name: Viread

Manufacturer: Gilead Sciences Canada Inc.

Therapeutic Area: Hepatitis B (chronic)

Indications: Hepatitis B (chronic)

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: March 18, 2009

Recommendation Type: List with clinical criteria and/or conditions